Véronique Hofman Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice Université Côte d’Azur, CHU de Nice Biography Publications Institution JoVE Articles Véronique Hofman has not added a biography. If you are Véronique Hofman and would like to personalize this page please email our Author Liaison for assistance. Publications The Need to Set Up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte D'Azur, Nice, France) Journal of Personalized Medicine. Jun, 2023 | Pubmed ID: 37511690 Epithelial-to-mesenchymal Transition Promotes Immune Escape by Inducing CD70 in Non-small Cell Lung Cancer European Journal of Cancer (Oxford, England : 1990). Jul, 2022 | Pubmed ID: 35550950 [Oncothoracic Pathology Seminar: Case No. 1] Annales De Pathologie. Mar, 2022 | Pubmed ID: 34998625 [Oncothoracic Pathology Seminar: Case No. 2] Annales De Pathologie. Mar, 2022 | Pubmed ID: 34996647 Salivary Detection of COVID-19: Clinical Performance of Oral Sponge Sampling for SARS-CoV-2 Testing ERJ Open Research. Oct, 2021 | Pubmed ID: 34877351 CT-guided Percutaneous Biopsies of Mediastinal and Paramediastinal Masses in the Lateral Decubitus Position European Radiology. Jun, 2020 | Pubmed ID: 32065281 Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France) Clinical Lung Cancer. Jan, 2020 | Pubmed ID: 31519454 A Case Report of Exogenous Lipoid Pneumonia Associated with Avocado/soybean Unsaponifiables BMC Pulmonary Medicine. Dec, 2019 | Pubmed ID: 31795982 [Pseudotumor Lesions Induced by Infectious Agents. Case N 5] Annales De Pathologie. Aug, 2019 | Pubmed ID: 31303345 [Pseudo Tumor Lesions Induced by Infectious Agents. Case N°6] Annales De Pathologie. Aug, 2019 | Pubmed ID: 31301879 Circulating Tumor Cell Detection in Lung Cancer: But to What End? Cancers. Feb, 2019 | Pubmed ID: 30813420 [The Age of Artificial Intelligence in Lung Cancer Pathology: Between Hope, Gloom and Perspectives] Annales De Pathologie. Apr, 2019 | Pubmed ID: 30772062 Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma Cancers. Sep, 2018 | Pubmed ID: 30216999 Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? Cancers. Jun, 2018 | Pubmed ID: 29966305 Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections Through the Encapsulation of Dried DNA Cancers. Jun, 2018 | Pubmed ID: 29891792 Effect of Mutant Variants of the KRAS Gene on PD-L1 Expression and on the Immune Microenvironment and Association with Clinical Outcome in Lung Adenocarcinoma Patients Lung Cancer (Amsterdam, Netherlands). Jul, 2018 | Pubmed ID: 29858030 E2F1 Inhibition Mediates Cell Death of Metastatic Melanoma Cell Death & Disease. 05, 2018 | Pubmed ID: 29743521 Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients Cancers. Mar, 2018 | Pubmed ID: 29561830 Any Place for Immunohistochemistry Within the Predictive Biomarkers of Treatment in Lung Cancer Patients? Cancers. Mar, 2018 | Pubmed ID: 29534030 Use of Circulating Tumor Cells in Prospective Clinical Trials for NSCLC Patients - Standardization of the Pre-analytical Conditions Clinical Chemistry and Laboratory Medicine. May, 2018 | Pubmed ID: 29397019 Circulating Tumour Cells As a Potential Screening Tool for Lung Cancer (the AIR Study): Protocol of a Prospective Multicentre Cohort Study in France BMJ Open. 12, 2017 | Pubmed ID: 29282271 Use of the 22C3 Anti-PD-L1 Antibody to Determine PD-L1 Expression in Multiple Automated Immunohistochemistry Platforms PloS One. 2017 | Pubmed ID: 28797130 Annales De Pathologie. Aug, 2017 | Pubmed ID: 28778623 Expression of MET in Circulating Tumor Cells Correlates with Expression in Tumor Tissue from Advanced-stage Lung Cancer Patients Oncotarget. Apr, 2017 | Pubmed ID: 28212540 [PD1/PD-L1 Immunohistochemistry in Thoracic Oncology: Where Are We?] Annales De Pathologie. Feb, 2017 | Pubmed ID: 28159404 Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer (Video) | JoVE Christophe Bontoux1,2,3,4,5, Virginie Lespinet-Fabre1,2,3,4, Olivier Bordone1,2,3,4, Virginie Tanga1,2,3,4, Maryline Allegra1,2,3,4, Myriam Salah1,2,3,4, Salomé Lalvée1,2,3,4, Samantha Goffinet1,2,3,4, Jonathan Benzaquen3,4,5,6, Charles-Hugo Marquette3,4,5,6, Marius Ilié1,2,3,4,5, Véronique Hofman1,2,3,4,5, Paul Hofman1,2,3,4,5 1Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, 2Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 3Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 4FHU OncoAge, Université Côte d'Azur, 5Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, 6Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur JoVE 65190 Biology Met behulp van 22C 3 Anti-PD-L1 antilichaam concentreren op biopsie en cytologie monsters van niet-kleincellige longkanker kankerpatiënten Marius Ilié1,2,3, Mélanie Ngo-Mai1, Elodie Long-Mira1,2, Sandra Lassalle1,2, Catherine Butori1, Coraline Bence1, Marame Hamila1, Véronique Hofman1,2,3, Paul Hofman1,2,3 1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, 2Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, 3Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur JoVE 58082 Cancer Research
Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer (Video) | JoVE Christophe Bontoux1,2,3,4,5, Virginie Lespinet-Fabre1,2,3,4, Olivier Bordone1,2,3,4, Virginie Tanga1,2,3,4, Maryline Allegra1,2,3,4, Myriam Salah1,2,3,4, Salomé Lalvée1,2,3,4, Samantha Goffinet1,2,3,4, Jonathan Benzaquen3,4,5,6, Charles-Hugo Marquette3,4,5,6, Marius Ilié1,2,3,4,5, Véronique Hofman1,2,3,4,5, Paul Hofman1,2,3,4,5 1Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, 2Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 3Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 4FHU OncoAge, Université Côte d'Azur, 5Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, 6Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur JoVE 65190 Biology
Met behulp van 22C 3 Anti-PD-L1 antilichaam concentreren op biopsie en cytologie monsters van niet-kleincellige longkanker kankerpatiënten Marius Ilié1,2,3, Mélanie Ngo-Mai1, Elodie Long-Mira1,2, Sandra Lassalle1,2, Catherine Butori1, Coraline Bence1, Marame Hamila1, Véronique Hofman1,2,3, Paul Hofman1,2,3 1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, 2Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, 3Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur JoVE 58082 Cancer Research